Monday, 16 November 2026
- Jefferies cuts Ibstock to underperform on covenant breach risk
Ibstock, the UK's largest brickmaker, has been downgraded to 'underperform' from 'hold' by Jefferies, which warned that weaker earnings could trigger a breach…
- Asda revival spells tougher times for Tesco and Sainsbury's, says Shore Capital
A recovering Asda threatens to make life harder for Tesco and J Sainsbury, according to retail analysts at Shore Capital.
- ASOS bond buyback marks another step in recovery, says Shore Capital
ASOS has taken another positive step in its recovery by buying back £90 million of expensive convertible bonds, according to Shore Capital.
- Deutsche Bank upgrades Croda as recovery gathers pace
Croda International has been upgraded to 'buy' from 'hold' by Deutsche Bank, which argues the shares have yet to catch up with the speciality chemicals group's…
- FTSE 100 LIVE: London share move higher as traders ignore Asian turmoil Update
London-listed miners led the FTSE 100 fallers on Monday after weak Chinese data, softer metals prices and a firmer US dollar hit the sector.
- Jefferies cuts Bellway to hold, sees better bets among housebuilders
Bellway has been downgraded to 'hold' from 'buy' by Jefferies, which believes investors will find better risk and reward elsewhere among UK housebuilders.
- Ninety One sticks to strategy in tough market after surprise £4.2bn outflows
Ninety One said it would stick to its strategy in an uncertain and "intensely competitive" market after clients unexpectedly pulled £4.2 billion in the first…
- ME Group's laundry growth offsets photobooth slowdown
ME Group International expects to report revenue of at least £309 million and adjusted pre-tax profit of at least £66 million for the year to October.
- Great Portland Estates sells Clifford Chance's new City HQ to Rothesay for £369m
Great Portland Estates has sold 2 Aldermanbury Square, the new City of London headquarters of law firm Clifford Chance, to Rothesay for a net £368.7 million.
- AstraZeneca lands four regulatory wins in blood pressure, bladder cancer and rare disease
AstraZeneca has secured four regulatory wins in a single morning, including a recommendation for EU approval of its new blood pressure pill Baxfendy.
- Legal & General on track to meet or beat all its strategic targets
Legal & General said it is on track to meet or exceed all the targets it set out in 2024.
- Ceres signs European fuel cell licence and guides to £60m revenue
Ceres Power has signed a manufacturing licence with an unnamed European partner, a deal that will take its revenue for this year to about £60 million.
- FTSE 100 LIVE: London set for quiet start after Asia's AI sell-off Update
Traders look set to ignore the AI maelstrom on the tech-focused Asian markets to open around 10 points in the green.
- Applied Nutrition holds guidance despite strong start as whey costs bite
Applied Nutrition has left its full-year forecasts unchanged despite a very strong first quarter, saying it is too early in the year to raise them.
- ASOS buys back £90 million of convertible bonds below market price
ASOS has agreed to buy back £90 million of its 11% convertible bonds due 2028, cutting its annual interest bill by about £6 million.
- FTSE 100 LIVE: Asian markets slide as AI jitters hit Japan, South Korea and Taiwan; Hong Kong bucks trend
Asian share markets were mostly lower on Monday as selling in technology and semiconductor stocks intensified ahead of Nvidia’s quarterly results and the…